HealthDay - FDA Approves Generic Risperdal
The first generic versions of the antipsychotic drug Risperdal (risperidone) were approved Monday by the U.S. Food and Drug Administration.
The generic versions in several strengths will be manufactured by Teva Pharmaceuticals USA. They will have the same boxed warnings as the brand name drug, produced by Janssen Pharmaceuticals.
Related Results
Antipsychotic treatment: when to measure prolactin.(Adult Psychiatry)
Patent challenge.(BARR Laboratories Inc., Janssen Pharmaceutica Products L.P….
Merrill Lynch Global Pharmaceutical, Biotechnology & Medical Device Confe…
CIBC World Markets Annual Biotechnology & Specialty Pharmaceuticals Confe…
WALL STREET CHOICE J&J SHARES REFLECT SLOWING PHARMA GROWTH
The so-called “black box” warning cautions that older people with dementia-related psychosis taking this class of drug, called atypical anti-psychotics, are at increased risk of death, the FDA said. These medicines aren’t approved to treat …
Read the full article with a Free Trial at MyWire.
